Affordable Access

deepdyve-link
Publisher Website

In silico screening of anti-inflammatory compounds from Lichen by targeting cyclooxygenase-2.

Authors
  • Joshi, Tanuja1
  • Sharma, Priyanka2
  • Joshi, Tushar1, 3
  • Chandra, Subhash1
  • 1 Department of Botany, Kumaun University, S.S.J Campus, Almora, Uttarakhand, India. , (India)
  • 2 Department of Botany, Kumaun University, D.S.B. Campus, Nainital, Uttarakhand, India. , (India)
  • 3 Department of Biotechnology, Bhimtal Campus, Kumaun University, Nainital, Uttarakhand, India. , (India)
Type
Published Article
Journal
Journal of biomolecular structure & dynamics
Publication Date
Aug 01, 2020
Volume
38
Issue
12
Pages
3544–3562
Identifiers
DOI: 10.1080/07391102.2019.1664328
PMID: 31524074
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Non-steroidal anti-inflammatory drugs (NSAID) targeting cyclooxygenase-2 are clinically effective. However, they lack anti-thrombotic activity resulting in incidences of adverse effects like myocardial infarction, gastrointestinal and abdominal discomfort which necessitate for discovering new drug candidates with improved therapeutic effects and tolerability. Various recent researches have suggested that many lichens offer a vast reservoir for anti-inflammatory drug candidates which are natural as well as safe for human consumption. Drug discovery is a very complex and time-consuming process; however, in silico techniques can make this process simple and economic. Hence to find out natural anti-inflammatory compounds, we have carried out the virtual screening of 412 lichen compounds by molecular docking with human Cox-2 enzyme and validated the docking score by X-Score followed by ADMET and Drug-likeness analysis. The resulting 6 top-scored compounds were subjected to Molecular dynamics simulation (MDS) to analyze the stability of docked protein-ligand complex, to assess the fluctuation and conformational changes during protein-ligand interaction. The values of RMSD, Rg, and interaction energy after 30 ns of MDS revealed the good stability of these Lichen compounds in the active site pocket of Cox-2 in compare to reference, JMS. Additionally, we have done the pharmacophore analysis which found many common pharmacophore features between Lichen compounds and well known anti-inflammatory compounds. Our result shows that these lichen compounds are potential anti-inflammatory candidates and could be further modified and evaluated to develop more effective anti-inflammatory drugs with fewer side effects for the treatment of inflammatory diseases.Communicated by Ramaswamy H. Sarma.

Report this publication

Statistics

Seen <100 times